Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Decreased Risk of Diabetes Mellitus Type II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00462436
What this trial is testing

Innovative Strategies For Risk Reduction Following CABG

Who this might be right for
Coronary Artery DiseaseType II Diabetes Mellitus
Unity Health Toronto 35
Not applicableStudy completedNCT04874116
What this trial is testing

Decreasing Cardiovascular Risk for Patients With Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Michigan State University 409
Not applicableUnknownNCT00300976
What this trial is testing

The Japan Diabetes Optimal Integrated Treatment Study for 3 Major Risk Factors of Cardiovascular Diseases

Who this might be right for
Cardiovascular DiseasesDiabetes Mellitus, Type 2
Japan Foundation for the Promotion of International Medical Research Cooperation 2,542
Not applicableUnknownNCT02686996
What this trial is testing

The Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk

Who this might be right for
Insulin Sensitivity
Monash University 84
Large-scale testing (Phase 3)Study completedNCT00069784
What this trial is testing

The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Sanofi 12,537
Not applicableStudy completedNCT06254339
What this trial is testing

Effects of OAGB and DJB-SG on 10-year and Lifetime Risks of MACE

Who this might be right for
Obesity
National Defense Medical Center, Taiwan 830
Not applicableUnknownNCT01301196
What this trial is testing

Reducing Sedentary Behaviour in Young Adults at Risk of Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Loughborough University 189
Large-scale testing (Phase 3)Study completedNCT00829296
What this trial is testing

Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries

Who this might be right for
HypertensionDiabetes
University of Chicago 70
Testing effectiveness (Phase 2)Looking for participantsNCT07783802
What this trial is testing

Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Who this might be right for
AtherosclerosisCardiovascular DiseaseObesity+3 more
Eli Lilly and Company 120
Not applicableStudy completedNCT00677599
What this trial is testing

The FLAVO Trial: Dietary Flavonoids and Cardiovascular Disease Risk Reduction in Postmenopausal Women With Type 2 Diabetes

Who this might be right for
Cardiovascular DiseaseDiabetes
University of East Anglia 152
Not applicableStudy completedNCT06025721
What this trial is testing

Behavior Change Intervention for Cardiovascular Risk Reduction Among People Experiencing Homelessness

Who this might be right for
Heart DiseasesDiabetes Mellitus, Type 2Pre-diabetes+2 more
Katherine Vickery 9
Not applicableStudy completedNCT04708574
What this trial is testing

Lifestyle Changes Reducing Type 2 Diabetes Risk Among Arab Canadian Muslim Women.

Who this might be right for
Lifestyle Risk ReductionType2 Diabetes
Western University, Canada 60
Not applicableUnknownNCT06117098
What this trial is testing

Mobile App for Risk Reduction of Type 2 Diabetes

Who this might be right for
Prediabetic State
Oslo Metropolitan University 60
Not applicableUnknownNCT01212328
What this trial is testing

A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South Asia

Who this might be right for
Type 2 Diabetes MellitusHypertensionDyslipidaemia
Public Health Foundation of India 1,120
Not applicableStudy completedNCT04981847
What this trial is testing

The Dietary Guidelines 3 Diets Study

Who this might be right for
Type 2 Diabetes
University of South Carolina 63
Not applicableLooking for participantsNCT06590519
What this trial is testing

Date Seed Extract Effectiveness in Controlling Diabetes and Cardiovascular Risk in T2DM

Who this might be right for
Type 2 Diabetes MellitusObesity
Universiti Putra Malaysia 160
Testing effectiveness (Phase 2)Study completedNCT00790517
What this trial is testing

Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)

Who this might be right for
Weight LossDiabetes Mellitus, Type 2Psychotic Disorders
Kaiser Permanente 200
Not applicableStudy completedNCT01818674
What this trial is testing

Microclinic Social Network Behavioral Health Trial in Jordan

Who this might be right for
Diabetes Mellitus, Type 2ObesityHypertension+17 more
Microclinic International 914
Not applicableStudy completedNCT00648284
What this trial is testing

Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects

Who this might be right for
Type 2 Diabetes MellitusCV Risk
GlaxoSmithKline 1,100
Post-approval studies (Phase 4)Study completedNCT01316367
What this trial is testing

Effectiveness of PRECEDE Model for Health Education on Changes and Level of Control in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusCardiovascular Risk Factor
Hospital Carlos III, Madrid 600
Next Page